Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.69 USD | -3.17% | -3.13% | +40.29% |
May. 13 | Baird Adjusts Price Target on Instil Bio to $32 From $54, Maintains Outperform Rating | MT |
May. 10 | Instil Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 69.53M |
---|---|---|---|---|---|
Net income 2024 * | -77M | Net income 2025 * | -74M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.94
x | P/E ratio 2025 * |
-1.09
x | Employees | 49 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 93.16% |
1 day | -3.17% | ||
1 week | -3.13% | ||
1 month | -1.20% | ||
3 months | -10.32% | ||
6 months | +57.76% | ||
Current year | +40.29% |
Managers | Title | Age | Since |
---|---|---|---|
Bronson Crouch
CEO | Chief Executive Officer | 51 | 18-10-31 |
Sandeep Laumas
DFI | Director of Finance/CFO | 56 | 20-05-31 |
Mark Dudley
CTO | Chief Tech/Sci/R&D Officer | - | 21-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Neil Gibson
BRD | Director/Board Member | 67 | 20-05-31 |
Richard McGaughy
BRD | Director/Board Member | 52 | 20-05-31 |
Director/Board Member | 49 | 20-06-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.03% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 10.69 | -3.17% | 5,005 |
24-05-30 | 11.04 | +4.15% | 3,675 |
24-05-29 | 10.6 | -3.28% | 8,748 |
24-05-28 | 10.96 | -0.68% | 14,662 |
24-05-24 | 11.04 | -1.82% | 13,480 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+40.29% | 69.53M | |
+43.36% | 54.64B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+0.04% | 12.16B | |
+25.12% | 12.21B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- TIL Stock